Israeli startup ProFuse Technology, which specializes in the cultivation of muscle tissue in laboratory conditions, has launched a new technology and program for discovering drugs that prevent muscle mass loss caused by the growing use of GLP-1 weight-loss injections, aging, and cancer.

Read more here.